(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

"Derivados Bicíclicos 6,6 ou 6,7 contendo pirito ou pirimido substituídos"

ArquivadaInvention PatentPCT · IB1997000918

Application data

Number

PI9710808

Type

Invention Patent

Filing

07/23/1997

Publication

08/17/1999

PCT

IB1997000918

Progress at the INPI

  1. Filing07/23/97
  2. Publication08/17/99
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 02/26/2008. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

Pfizer Inc

US

See this company's full portfolio

Inventors

Y. C. (pessoa física)

US

Technical data

Priority claims

US

023453 · 08/06/1996

Abstract

Patente de Invenção: "DERIVADOS BICÍCLICOS 6,6 OU 6,7 CONTENDO PIRIDO SUBSTITUÍDOS" . Esta invenção refere-se a compostos da fórmula em que A, B, D, E, K, G, Z, R^ 3^ e R^ 5^ são definidos de acordo com o relatório descritivo, e aos sais farmaceuticamente aceitáveis de tais compostos. Os compostos (I) são antagonistas do fator (hormônio) de liberação de corticotropina CRF (CRH).

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

02/26/2008

RPI 1938

Republicação - classificação IPC

#15.11

Alteração da Int.Cl.8: C07D 217/22, A61K 31/00, A61K 31/435, A61K 31/4353, A61K 31/436, A61K 31/437, A61K 31/4375, A61K 31/5365, A61K 31/4985, A61K 31/505, A61K 31/519, A61K 31/535, A61K 31/5365, A61P 3/04, A61P 5/38, A61P 25/28, A61P 43/00, C07D 217/24, C07D 471/04, C07D 419/502, C07D 498/04

05/29/2007

RPI 1899

Exigência - art. 36 da LPI

#6.1

05/29/2007

RPI 1899

Notificação de entrada na fase nacional - PCT

#1.3

08/17/1999

RPI 1493

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.